A citation-based method for searching scientific literature

Anne Vincent-Salomon, Carlo Lucchesi, Nadège Gruel, Virginie Raynal, Gaëlle Pierron, Rémi Goudefroye, Fabien Reyal, François Radvanyi, Rémy Salmon, Jean-Paul Thiery, Xavier Sastre-Garau, Brigitte Sigal-Zafrani, Alain Fourquet, Olivier Delattre. Clin Cancer Res 2008
Times Cited: 111



D Craig Allred, Yun Wu, Sufeng Mao, Iris D Nagtegaal, Sangjun Lee, Charles M Perou, Syed K Mohsin, Peter O'Connell, Anna Tsimelzon, Dan Medina. Clin Cancer Res 2008
Times Cited: 202




List of shared articles



Times cited

Atypia in breast pathology: what pathologists need to know.
Ayaka Katayama, Michael S Toss, Matthew Parkin, Ian O Ellis, Cecily Quinn, Emad A Rakha. Pathology 2022
0


Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence.
Vidya C Sinha, Helen Piwnica-Worms. J Mammary Gland Biol Neoplasia 2018
7

The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast.
Hugo Villanueva, Sandra Grimm, Sagar Dhamne, Kimal Rajapakshe, Adriana Visbal, Christel M Davis, Erik A Ehli, Sean M Hartig, Cristian Coarfa, Dean P Edwards. J Mammary Gland Biol Neoplasia 2018
6

Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.
Carlos R Gil Del Alcazar, Sung Jin Huh, Muhammad B Ekram, Anne Trinh, Lin L Liu, Francisco Beca, Xiaoyuan Zi, Minsuk Kwak, Helga Bergholtz, Ying Su,[...]. Cancer Discov 2017
105

Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis.
Kylie L Gorringe, Stephen B Fox. Front Oncol 2017
56

p63/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer.
C Lodillinsky, E Infante, A Guichard, R Chaligné, L Fuhrmann, J Cyrta, M Irondelle, E Lagoutte, S Vacher, H Bonsang-Kitzis,[...]. Oncogene 2016
57

Ductal carcinoma in situ - update on risk assessment and management.
Jia-Min B Pang, Kylie L Gorringe, Stephen B Fox. Histopathology 2016
29

AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin.
Christophe Couderc, Alizée Boin, Laetitia Fuhrmann, Anne Vincent-Salomon, Vinay Mandati, Yann Kieffer, Fatima Mechta-Grigoriou, Laurence Del Maestro, Philippe Chavrier, David Vallerand,[...]. Neoplasia 2016
23

Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer.
Robert Lesurf, Miriam Ragle Aure, Hanne Håberg Mørk, Valeria Vitelli, Steinar Lundgren, Anne-Lise Børresen-Dale, Vessela Kristensen, Fredrik Wärnberg, Michael Hallett, Therese Sørlie. Cell Rep 2016
48

Cancer stem cells and early stage basal-like breast cancer.
Pang-Kuo Lo, Benjamin Wolfson, Qun Zhou. World J Obstet Gynecol 2016
5

Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast.
Jia-Min B Pang, Kylie L Gorringe, Stephen Q Wong, Alexander Dobrovic, Ian G Campbell, Stephen B Fox. Breast Cancer Res 2015
5


Molecular classification of breast cancer.
Darina Vuong, Peter T Simpson, Benjamin Green, Margaret C Cummings, Sunil R Lakhani. Virchows Arch 2014
86

Alu and LINE-1 hypomethylation is associated with HER2 enriched subtype of breast cancer.
So Yeon Park, An Na Seo, Hae Yoen Jung, Jae Moon Gwak, Namhee Jung, Nam-Yun Cho, Gyeong Hoon Kang. PLoS One 2014
46

Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients.
Dana Pape-Zambito, Zhengyu Jiang, Hong Wu, Karthik Devarajan, Carolyn M Slater, Kathy Q Cai, Arthur Patchefsky, Mary B Daly, Xiaowei Chen. PLoS One 2014
15

Molecular Markers as Prognostic Factors in DCIS and Small Invasive Breast Cancers.
N Sänger, K Engels, A Graf, E Ruckhäberle, K E Effenberger, T Fehm, U Holtrich, S Becker, T Karn. Geburtshilfe Frauenheilkd 2014
8


Ductal carcinoma in situ: morphology-based knowledge and molecular advances.
Dara S Ross, Yong Hannah Wen, Edi Brogi. Adv Anat Pathol 2013
8

Is there a low-grade precursor pathway in breast cancer?
Tari A King, Rita A Sakr, Shirin Muhsen, Victor P Andrade, Dilip Giri, Kimberly J Van Zee, Monica Morrow. Ann Surg Oncol 2012
14

Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection.
Lucia Hernandez, Paul M Wilkerson, Maryou B Lambros, Adriana Campion-Flora, Daniel Nava Rodrigues, Arnaud Gauthier, Cecilia Cabral, Vidya Pawar, Alan Mackay, Roger A'Hern,[...]. J Pathol 2012
109

High Ki67 expression is a risk marker of invasive relapse for classical lobular carcinoma in situ patients.
Anne Vincent-Salomon, David Hajage, Alexandre Rouquette, Aurélie Cédenot, Nadège Gruel, Séverine Alran, Xavier Sastre-Garau, Brigitte Sigal-Zafrani, Alain Fourquet, Youlia Kirova. Breast 2012
10

Cell polarity, epithelial-mesenchymal transition, and cell-fate decision gene expression in ductal carcinoma in situ.
Danila Coradini, Patrizia Boracchi, Federico Ambrogi, Elia Biganzoli, Saro Oriana. Int J Surg Oncol 2012
6

FGFR1 is amplified during the progression of in situ to invasive breast carcinoma.
Min Jang, Eun Kim, Yoomi Choi, Hee Lee, Yu Kim, Jee Kim, Eunyoung Kang, Sung-Won Kim, In Kim, So Park. Breast Cancer Res 2012
59

Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression.
Kerstin Heselmeyer-Haddad, Lissa Y Berroa Garcia, Amanda Bradley, Clarymar Ortiz-Melendez, Woei-Jyh Lee, Rebecca Christensen, Sheila A Prindiville, Kathleen A Calzone, Peter W Soballe, Yue Hu,[...]. Am J Pathol 2012
73


Human primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft model.
Kelli Elizabeth Valdez, Fang Fan, William Smith, D Craig Allred, Daniel Medina, Fariba Behbod. J Pathol 2011
54

Breast cancer precursors revisited: molecular features and progression pathways.
Maria A Lopez-Garcia, Felipe C Geyer, Magali Lacroix-Triki, Caterina Marchió, Jorge S Reis-Filho. Histopathology 2010
188

Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.
Udo Rudloff, Lindsay M Jacks, Jessica I Goldberg, Christine A Wynveen, Edi Brogi, Sujata Patil, Kimberly J Van Zee. J Clin Oncol 2010
201

Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer.
Aslaug Aamodt Muggerud, Michael Hallett, Hilde Johnsen, Kristine Kleivi, Wenjing Zhou, Simin Tahmasebpoor, Rose-Marie Amini, Johan Botling, Anne-Lise Børresen-Dale, Therese Sørlie,[...]. Mol Oncol 2010
80